“…From forty-nine studies, the overall pooled prevalence of LP in HCV patients was 7.05% (95% CI, 4.85–9.26%). From these, in thirty-four cohorts, the overall pooled prevalence of LP was 7.75 (95% CI 4.84–10.66%) in patients with HCV [ 179 , 180 , 181 , 182 , 183 , 184 , 185 , 186 , 187 , 188 , 189 , 190 , 191 , 192 , 193 , 194 , 195 , 196 , 197 , 198 , 199 , 200 , 201 , 202 , 203 , 204 , 205 , 206 ]. Detailed information on the sample to the included studies is provided in Supplemental Table S2 .…”